Viewing Study NCT01762202

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2026-02-26 @ 12:36 AM
Study NCT ID: NCT01762202
Status: COMPLETED
Last Update Posted: 2020-10-14
First Post: 2013-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia.
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Lymphoid Leukemia View
None Young Patients View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLL View
None Fludarabine View
None Cyclophosphamide View
None Ofatumumab View